Perspectives on Trypanosoma cruzi-Induced Heart Disease (Chagas Disease)

Progress in Cardiovascular Diseases

Volumn 51, Issue 6, 2009, Pages 524-539

  Tanowitz, Herbert B ^a,b,c,d,e   Machado, Fabiana S ^a,b,c,d,e   Jelicks, Linda A ^a,b,c,d,e   Shirani, Jamshid ^a,b,c,d,e   Campos de Carvalho, Antonio C ^a,b,c,d,e   Spray, David C ^a,b,c,d,e   Factor, Stephen M ^a,b,c,d,e   Kirchhoff, Louis V ^a,b,c,d,e   Weiss, Louis M ^a,b,c,d,e  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d GEISINGER MEDICAL CENTER   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTIFUNGAL AGENT; ANTIPARASITIC AGENT; BENZNIDAZOLE; IMMUNOSUPPRESSIVE AGENT; NIFURTIMOX; TRYPANOSOMA VACCINE; VERAPAMIL;

ARTICLE; AUTOIMMUNITY; CARDIOMYOPATHY; CHAGAS DISEASE; CLINICAL TRIAL; DISEASE COURSE; ECHOCARDIOGRAPHY; GAP JUNCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MICROANGIOPATHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASITE VIRULENCE; PATHOGENESIS; PROGNOSIS; SERODIAGNOSIS; SOUTH AND CENTRAL AMERICA; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; VACCINE PRODUCTION;

ANIMALS; BRAZIL; CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; ENDEMIC DISEASES; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; LIFE CYCLE STAGES; MAGNETIC RESONANCE IMAGING; MUSCLE CELLS; SOUTH AMERICA; TRYPANOSOMA CRUZI;

EID: 65349130738     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2009.02.001     Document Type: Article

References (107)

1. Tanowitz H.B., Kirchhoff L.V., Simon D., et al. Chagas' disease. Clin Microbiol Rev 4 (1992) 400-419
2. Kierszenbaum F. Mechanisms of pathogenesis in Chagas disease. Acta Parasitologica 52 (2007) 1-12
3. Marin-Neto A.J., Cunha-Neto E., Maciel B.C., et al. Pathogenesis of chronic Chagas disease. Circulation 115 (2007) 1109-1121
4. Moncayo A., and Ortizyanine M.I. Centennial review: an update on Chagas disease (human American trypanosomiasis). Ann Trop Med Parasitol 100 (2006) 663-677
5. Tarleton R.L., Reithinger R., Urbina J.A., et al. The challenges of Chagas Disease-grim outlook or glimmer of hope. PLoS Med 4 (2007) 1852-1857
6. Chagas C. Nova tripanosomíase humana: estudos sobre a morfologia e o ciclo evolutivo do Schizotrypanum cruzi n.g., n.sp., agente etiológico de nova entidade mórbida no homem. Mem Inst Oswaldo Cruz 1 (1909) 159-218
7. Chagas C. Nova entidade mórbida do homem: Resumo geral de estudos etiológicos e clínicos. Mem Inst Osw Cruz 3 (1911) 219-275
8. Lewinsohn R. Prophet in his own country, Carlos Chagas and the Nobel Prize. Perspect Biol Med 46 (2003) 532-549
9. Aufderheide A.C., Salo W., Madden M., et al. A 9,000-year record of Chagas' disease. Proc Natl Acad Sci U S A 101 (2004) 2034-2039
10. Anonymous MMWR Blood Donor Screening for Chagas Disease-United States, 2006-2007. 56: 141-143, 2007
11. Bern C., Montgomery S.P., Katz L., et al. Chagas disease and the US blood supply. Curr Opin Infect Dis 21 (2008) 476-482
12. Combs T.P., Nagajyothi F., Mukherjee S., et al. The adipocyte as an important target cell for Trypanosoma cruzi infection. J Biol Chem 280 (2005) 24085-24094
13. Cohen J.E., and Gürtler R.E. Modeling household transmission of American trypanosomiasis. Science 293 (2001) 694-698
14. Laranja F.S., Dias E., Nobrega G., et al. Chagas' disease: a clinical, epidemiological and pathologic study. Circulation 14 (1956) 1035-1060
15. Kirchhoff L.V. American trypanosomiasis. Gastroenterol Clin North Am 25 (1996) 517-533
16. Parada H., Carrasco H.A., Añez N., et al. Cardiac involvement is a constant finding in acute Chagas disease: a clinical, parasitological and histopathological study. Int J Cardiol 60 (1997) 49-54
17. Salvatella R. Current status of Chagas disease (2006), Pan American Health Organization, Washington, DC
18. Ribeiro A.L., Teixeira M.M., Reis A.M., et al. Brain natriuretic peptide based strategy to detect left ventricular dysfunction in Chagas disease: a comparison with the conventional approach. Int J Cardiol 109 (2006) 34-40
19. Costa G.C., Rocha M.O., Moreira P.R., et al. Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. J Infect Dis 199 (2009) 451-454
20. Rassi Jr. A., Rassi A., Little W.C., et al. Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med 355 (2006) 799-808
21. Acquatella H. Echocardiography in Chagas heart disease. Circulation 115 (2007) 1124-1131
22. Barros M.V.L., Rocha M.O.C., Ribeiro A.L.P., et al. Doppler tissue imaging to evaluate early myocardium damage in patients with undetermined form of Chagas disease and normal echocardiogram. Echocardiography 18 (2001) 131-136
23. Viotti R.J., Vigliano C., Laucella S., et al. Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure. Heart 90 (2004) 655-660
24. Aquatella H., Schiller N.B., Puigbó J.J., et al. M-mode and two-dimensional echocardiography in chronic Chagas' heart disease. Circulation 62 (1980) 787-799
25. Marin-Neto J.A., Marzullo P., Marcassa C., et al. Myocardial perfusion defects in chronic Chagas' disease: assessment with thallium-201 scintigraphy. Am J Cardiol 69 (1992) 780-784
26. Tanowitz H.B., Huang H., Jelicks L.A., et al. Role of endothelin 1 in the pathogenesis of chronic chagasic heart disease. Infect Immun 73 (2005) 2496-2503
27. Ueno Y., Nakamura Y., Takahashi M., et al. A highly suspected case of chronic Chagas' heart disease diagnosed in Japan. Jpn Circ J 59 (1995) 219-223
28. Marcu C.B., Beek A.M., and van Rossum A.C. Chagas' heart disease diagnosed on MRI: the importance of patient "geographic" history. Int J Cardiol 117 (2007) e58-e60
29. Rochitte C.E., Nacif M.S., Júnior A.C., et al. Cardiac magnetic resonance in Chagas' disease. Artif Organs 31 (2007) 259-267
30. Sechtem U., Mahrholdt H., and Vogelsberg H. Cardiac magnetic resonance in myocardial disease. Heart 93 (2007) 1520-1527
31. Jelicks L.A., Shirani J., Wittner M., et al. Application of cardiac gated magnetic resonance imaging in murine Chagas' disease. Am J Trop Med Hyg 61 (1999) 207-214
32. Durand J.L., Tang B., Gutstein D.E., et al. Dyskinesis in Chagasic myocardium: centerline analysis of wall motion using cardiac-gated magnetic resonance images of mice. Magn Reson Imaging 24 (2006) 1051-1057
33. Huang H., Chan J., Wittner M., et al. Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J Mol Cell Cardiol 31 (1999) 75-88
34. Jelicks L.A., Chandra M., Shirani J., et al. Cardioprotective effects of phosphoramidon on myocardial structure and function in murine Chagas' disease. Int J Parasitol 32 (2002) 1497-1506
35. Machado F.S., Souto J.T., Rossi M.A., et al. Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytes. Microbes Infect 10 (2008) 1558-1566
36. Gutierrez F.R.S., Lalu M.M., Mariano F.S., et al. Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi Infection. J Infect Dis 197 (2008) 1468-1476
37. Higuchi M., Fukasawa S., de Brito T., et al. Different microcirculatory and interstitial matrix patterns in idiopathic dilated cardiomyopathy and Chagas' disease: a three dimensional confocal microscopy study. Heart 82 (1999) 279-286
38. Martin D.L., and Tarleton R.L. Antigen-specific T cells maintain an effector memory phenotype during persistent Trypanosoma cruzi infection. J Immunol 174 (2005) 1594-1601
39. + T-cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog 2 (2006) e77
40. Huang H., Petkova S.B., Cohen A.W., et al. Activation of Transcription factors (AP-1 and NF-κB) in murine chagasic myocarditis. Activation of transcription factors AP-1 and NF-κB in murine chagasic myocarditis. Infect Immun 71 (2003) 2567-2859
41. Nagajyothi F., Desruisseaux M., Bouzahzah B., et al. Cyclin and caveolin expression in an acute model of murine chagasic myocarditis. Cell Cycle 5 (2006) 107-112
42. Petkova S.B., Ashton A., Bouzahzah B., et al. Cell cycle molecules and diseases of the cardiovascular system. Front Biosci 5 (2000) D452-D460
43. Petkova S.B., Huang H., Factor S.M., et al. The role of endothelin in the pathogenesis of Chagas' disease. Int J Parasitol 31 (2001) 499-511
44. Petersen C.A., Krumholz K.A., Carmen J., et al. Trypanosoma cruzi infection and nuclear factor kappa B activation prevent apoptosis in cardiac cells. Infect Immun 74 (2006) 1580-1587
45. Rossi M.A., and Souza A.C. Is apoptosis a mechanism of cell death of cardiomyocytes in chronic chagasic myocarditis?. Int J Cardiol 68 (1999) 325-331
46. Zhang J., Andrade Z.A., Yu Z.X., et al. Apoptosis in a canine model of acute chagasic myocarditis. J Mol Cell Cardiol 31 (1999) 581-596
47. Tarleton R.L. Parasite persistence in the aetiology of Chagas disease. Int J Parasitol 31 (2001) 550-554
48. Jones E.M., Colley D.G., Tostes S., Lopes E.R., Vnencak-Jones C.L., and McCurley T.L. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg 48 (1993) 348-357
49. Jorg M.E. Destrucción de vasos capilares, miocitolisis y aneurisma apical en la cardiopatia chagásica. Prensa Med Argent 67 (1980) 490-494
50. Jorg M.E. Tripanosomiasis cruzi: anarquía angiotopográfica por descapilarizaclón mesequimorreactiva, cofactor patogénico de la miocardiopatía crónica. Prensa Med Argent 61 (1974) 94-105
51. Rossi M., and Ramos S. Coronary microvascular abnormalities in Chagas' disease. Am Heart J 132 (1996) 207-210
52. Sonnenblick E.H., Fein F., Capasso J.M., et al. Microvascular spasm as a cause of cardiomyopathies and the calcium-blocking agent verapamil as potential primary therapy. Am J Cardiol 55 (1985) 179B-184B
53. Factor S.M., Cho S., Wittner M., et al. Abnormalities in the microcirculation in Chagas' disease. Am J Trop Med Hyg 34 (1985) 246-253
54. Tanowitz H.B., Kaul D.K., Chen B., et al. Compromised microcirculation in acute Trypanosoma cruzi infection. J Parasitol 82 (1996) 124-130
55. Huang H., Calderon T.M., Berman J.W., et al. Infection of endothelial cells with Trypansoma cruzi activates NF-κB and induces vascular adhesion molecule expression. Infect Immun 67 (1999) 5434-5440
56. Chandra M., Shirani J., Shtutin V., Weiss L.M., et al. Cardioprotective effects of verapamil on myocardial structure and function in a murine model of chronic Trypanosoma cruzi infection (Brazil strain): an echocardiographic study. Int J Parasitol 32 (2002) 207-215
57. de Souza A.P., Tanowitz H.B., Chandra M., et al. Effects of early and late verapamil administration on the development of cardiomyopathy in experimental chronic Trypanosoma cruzi (Brazil strain) infection. Parasitol Res 92 (2004) 496-501
58. 2 is a key regulator of pathogenesis during Trypanosoma cruzi infection. J Exp Med 204 (2007) 929-940
59. Bonney K.M., and Engman D.M. Chagas heart disease pathogenesis: one mechanism or many?. Curr Mol Med 8 (2008) 510-518
60. Simoes M.V., Pintya A.O., Bromberg-Marin G., et al. Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas' cardiomyopathy. Am J Cardiol 86 (2000) 975-981
61. Wen J.J., Vyatkina G., and Garg N. Oxidative damage during chagasic cardiomyopathy development: role of mitochondrial oxidant release and inefficient antioxidant defense. Free Radic Biol Med 37 (2004) 1821-1833
62. Wen J.J., Yachelini P.C., Sembaj A., et al. Increased oxidative stress is correlated with mitochondrial dysfunction in chagasic patients. Free Radic Biol Med 41 (2006) 270-276
63. Wen J.J., Dhiman M., Whorton E.B., et al. Tissue-specific oxidative imbalance and mitochondrial dysfunction during Trypanosoma cruzi infection in mice. Microbes Infect 10 (2008) 1201-1209
64. Wen J.J., Bhatia V., Popov V.L., et al. Phenyl-alpha-tert-butyl nitrone reverses mitochondrial decay in acute Chagas' disease. Am J Pathol 169 (2006) 1953-1964
65. Elizari M.V., and Chiale P.A. Cardiac arrhythmias in Chagas' heart disease. J Cardiovasc Electrophysiol 4 (1993) 596-608
66. Severs N.J., Dupont E., Thomas N., et al. Alterations in cardiac connexin expression in cardiomyopathies. Adv Cardiol 42 (2008) 228-242
67. Campos de Carvalho A.C., Masuda M.O., et al. Conduction defects and arrhythmias in Chagas' disease: possible role of gap junctions and humoral mechanisms. J Cardiovasc Electrophysiol 5 (1994) 686-698
68. Campos de Carvalho A.C., Tanowitz H.B., Wittner M., et al. Gap junction distribution is altered between cardiac myocytes infected with Trypanosoma cruzi. Circ Res 70 (1992) 733-742
69. Mukherjee S., Belbin T.J., Spray D.C., et al. Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy. Parasitol Res 91 (2003) 187-196
70. Mukherjee S., Nagajyothi F., Mukhopadhyay A., et al. Alterations in myocardial gene expression associated with experimental Trypanosoma cruzi infection. Genomics 91 (2008) 423-432
71. Adesse D., Garzoni L.R., Huang H., et al. Trypanosoma cruzi induces changes in cardiac connexin43 expression. Microbes Infect 10 (2008) 21-28
72. Chang C.D., Cheng K.Y., Jang L.X., et al. Evaluation of a prototype Trypanosoma cruzi antibody assay with recombinant antigens on a fully automated chemiluminescence analyzer for blood donor screening. Transfusion 46 (2006) 1737-1744
73. Cheng K.Y., Chang C.D., Salbilla V.A., et al. Immunoblot assay using recombinant antigens as a supplemental test to confirm the presence of antibodies to Trypanosoma cruzi. Clin Vaccine Immunol 14 (2007) 355-361
74. Bern C., Montgomery S.P., Herwaldt B.L., et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 298 (2007) 2171-2181
75. Campos S.V., Strabelli T.M., Amato Neto V., et al. Risk factors for Chagas' disease reactivation after heart transplantation. J Heart Lung Transplant 27 (2008) 597-602
76. Soonpaa M.K., Koh G.Y., Klug M.G., et al. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 264 (1994) 98
77. Makino S., Fukuda K., Miyoshi S., et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103 (1999) 69
78. Tomita S., Li R.K., Weisel R.D., et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100 suppl. II (1999) 247-256
79. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
80. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 (2001) 430-436
81. Toma C., Pittenger M.F., Cahill K.S., et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105 (2002) 93-98
82. Murry C.E., Soonpaa M.H., Reinecke H., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
83. Balsam L.B., Wagers A.J., Christenson J.L., et al. Haematopoitec stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428 (2004) 668-673
84. Nygren J.M., Jovinge S., Breitbach M., et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 10 (2004) 494-501
85. Mangi A., Noiseux N., Kong D., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9 (2003) 1195-1201
86. Gnecchi M., He H., Liang O.D., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11 (2005) 367-368
87. Dawn B., Guo Y., Rezazadeh A., et al. Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res 98 (2006) 1098-1105
88. Soares M.B.P., Lima R.S., Rocha L.L., et al. Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic chagasic mice. Am J Pathol 164 (2004) 441-447
89. Goldenberg R.C., Jelicks L.A., Fortes F.S., et al. Bone marrow cell therapy ameliorates and reverses chagasic cardiomyopathy in a mouse model. J Infect Dis 197 (2008) 544-547
90. Harada M., Qin Y., Takano H., et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 11 (2005) 305-311
91. Guarita-Souza L.C., Carvalho K.A.T., Woitowicz V., et al. Simultaneous autologous transplantation of cocultured mesenchymal stem cells and skeletal myoblasts improves ventricular function in a murine model of Chagas disease. Circulation 114 1 Suppl (2006) I120-I124
92. Jacob J.L.B., Vilela Salis F., and Ruiz M.A. Labeled stem cells transplantation to the myocardium of a patient with Chagas' disease. Arq Bras Cardiol 89 (2007) e10-e11
93. Vilas-Boas F., Feitosa G.S., Soares M.B.P., et al. Early results of bone marrow cell transplantation to the myocardium of patients with heart failure due to Chagas disease. Arq Bras Cardiol 87 (2006) 159-166
94. Cantarovich F., Vasquez M., Duro-Garcia W.D., et al. Special infections in organ transplantation in South America. Transplant Proc 24 (1992) 1902-1908
95. Vaidian A.K., Weiss L.M., and Tanowitz H.B. Chagas' disease and AIDS. Kinetoplastid Biol Dis 13 (2004) 2
96. Kohl S., Pickering L.K., Frankel L.S., and Yaeger R. Reactivation of Chagas' disease during therapy of acute lymphocytic leukemia. Cancer 50 (1992) 827-828
97. Rezende R., Lescano M.A., Ramalho L., et al. Reactivation of Chagas' disease in a patient with non-Hodgkins lymphoma; gastric, oesophageal and laryngeal involvement. Trans Roy Soc Trop Med Hyg 100 (2006) 74-78
98. Del Castillo M., Mendoza M., Oviedo J., et al. AIDS and Chagas' disease with central nervous system tumor-like lesion. Am J Med 88 (1990) 693-694
99. Sartori A.M., Ibrahim K.Y., Nunes Westphalen E.V., et al. Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Ann Trop Med Parasitol 101 (2007) 31-50
100. Sartori A.M., Caiaffa-Filho H.H., Bezerra R.C., et al. Exacerbation of HIV viral load with asymptomatic reactivation of chronic Chagas disease. Am J Trop Med Hyg 67 (2002) 521-523
101. Sartori A.M., Lopes M.H., Benvenuti L.A., et al. Reactivation of Chagas' disease in a human immunodeficiency virus-infected patient leading to severe heart disease with a late positive direct microscopic examination of the blood. Am J Trop Med Hyg 59 (1998) 784-786
102. Lages-Silva E., Ramirez L.E., Silva-Vergara M., and Chiari E. Chagasic meningoencephalitis in a patient with acquired immunodeficiency syndrome, diagnosis, follow-up, and genetic characterization of Trypanosoma cruzi. Clin Infect Dis 34 (2002) 118-123
103. Rocha A., de Meneses A.C., and da Silva A.M. Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. Am J Trop Med Hyg 50 (1994) 261-268
104. Cordova E., Boschi A., Ambrosioni J., et al. Reactivation of Chagas disease with central nervous system involvement in HIV-infected patients in Argentina, 1992-2007. Int J Infect Dis 12 (2008) 587-592
105. Fontanella G., De Vusser K., Laroy W., et al. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate. Vaccine 26 (2008) 2322-2334
106. Zacks M.A., and Garg N. Recent developments in the molecular, biochemical and functional characterization of GPI8 and the GPI-anchoring mechanism. Mol Membr Biol 23 (2006) 209-225
107. Bhatia V., and Garg N.J. Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice. Clin Vaccine Immunol 15 (2008) 1158-1164